Skip to content

Resources

The Latest

  • Latest Blog Article

    HHS’s Peptide Compounding Policy: What Healthcare Businesses Need to Know

    The new enforcement discretion policy released by the US Department of Health and Human Services (HHS) marks a shift in the regulatory landscape for peptide compounding. The policy outlines conditions under which FDA intends to exercise enforcement discretion for compounding involving six specific peptide ingredients (BPC-157 acetate, TB-500 acetate, Epitalon acetate, Semax free base, KPV…

    November 2, 2026

Fraud Risk and Prevention

  • Upcoming Webinar

    The Naughty List: Unwrapping the Holiday Scam Surge

    Thursday, November 12 at 1 p.m. Eastern | 10 a.m. Pacific

    Holiday scams are set up months ahead and switch on in Q4, when record online spending gives them cover. Chargebacks land 60 to 120 days later, after the merchant is gone. LegitScript and a panel of risk and fraud experts break down fraudulent merchants, mass marketing fraud, and AI-driven fraud, plus the controls that still work this late.

High Risk and Problematic Products

  • Latest Blog Article

    HHS’s Peptide Compounding Policy: What Healthcare Businesses Need to Know

    The new enforcement discretion policy released by the US Department of Health and Human Services (HHS) marks a shift in the regulatory landscape for peptide compounding. The policy outlines conditions under which FDA intends to exercise enforcement discretion for compounding involving six specific peptide ingredients (BPC-157 acetate, TB-500 acetate, Epitalon acetate, Semax free base, KPV…

    November 2, 2026

High Risk Businesses and Services

  • Upcoming Webinar

    The Naughty List: Unwrapping the Holiday Scam Surge

    Thursday, November 12 at 1 p.m. Eastern | 10 a.m. Pacific

    Holiday scams are set up months ahead and switch on in Q4, when record online spending gives them cover. Chargebacks land 60 to 120 days later, after the merchant is gone. LegitScript and a panel of risk and fraud experts break down fraudulent merchants, mass marketing fraud, and AI-driven fraud, plus the controls that still work this late.

Regulatory and Card Brand Compliance

  • Latest Blog Article

    HHS’s Peptide Compounding Policy: What Healthcare Businesses Need to Know

    The new enforcement discretion policy released by the US Department of Health and Human Services (HHS) marks a shift in the regulatory landscape for peptide compounding. The policy outlines conditions under which FDA intends to exercise enforcement discretion for compounding involving six specific peptide ingredients (BPC-157 acetate, TB-500 acetate, Epitalon acetate, Semax free base, KPV…

    November 2, 2026

E-commerce Risk and Compliance

  • Featured Guide

    US, UK, and EU Product Safety Three-Market Comparison

    This report compares the product
    safety alert intelligence for three jurisdictions with some of the strictest product safety measures: the
    United States, the European Union, and the United Kingdom. By understanding how these regulatory bodies differ and where they align on enforcement priorities, online platforms can better strategize to reduce risk.

    7 pages

Addiction Treatment and Recovery Programs

  • Latest Blog Article

    HHS’s Peptide Compounding Policy: What Healthcare Businesses Need to Know

    The new enforcement discretion policy released by the US Department of Health and Human Services (HHS) marks a shift in the regulatory landscape for peptide compounding. The policy outlines conditions under which FDA intends to exercise enforcement discretion for compounding involving six specific peptide ingredients (BPC-157 acetate, TB-500 acetate, Epitalon acetate, Semax free base, KPV…

    November 2, 2026